SEC 13F Intelligence

Sassicaia Capital Advisers LLC / AXSM

Sassicaia Capital Advisers LLC’s Axsome Therapeutics Inc. Position

Does Sassicaia Capital Advisers LLC own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 24.0K shares worth $2M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q2 2023
Shares
24.0K
% of Portfolio
+1.48%
Quarters Held
2
position exited

Position History AXSM

Reported value by quarter
Q4 ’22: $277,668Q4 ’22Q2 ’23: $2MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202324.0K$2M+1.48%
Q4 20223.6K$277,668+0.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sassicaia Capital Advisers LLC’s full portfolio or all institutional holders of AXSM.